Literature DB >> 14596885

NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity.

Per A Albertsson1, Per H Basse, Marianne Hokland, Ronald H Goldfarb, J Fred Nagelkerke, Ulf Nannmark, Peter J K Kuppen.   

Abstract

Although it is clear that natural killer (NK) cells have the ability to recognize and kill tumour cells in vitro, their potential as a highly effective treatment for tumours has not yet been realized in the clinical setting. Following activation, endogenous and adoptively transferred NK cells can be found in tumours. However, not all tumours are equally well-infiltrated, and many of the infiltrating cells do not make target-cell contact but rather reside in the tumour stroma. New insights into the migration of NK cells, their activation status and production of matrix-degrading proteases might help to overcome this localization defect, with implications for the treatment of human cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596885     DOI: 10.1016/j.it.2003.09.007

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  64 in total

Review 1.  Are circadian rhythms the code of hypothalamic-immune communication? Insights from natural killer cells.

Authors:  Alvaro Arjona; Dipak K Sarkar
Journal:  Neurochem Res       Date:  2007-10-27       Impact factor: 3.996

2.  Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment.

Authors:  Pulak Ranjan Nath; Dipasmita Pal-Nath; Ajeet Mandal; Margaret C Cam; Anthony L Schwartz; David D Roberts
Journal:  Cancer Immunol Res       Date:  2019-07-30       Impact factor: 11.151

Review 3.  NK cells: key to success of DC-based cancer vaccines?

Authors:  Eva Lion; Evelien L J M Smits; Zwi N Berneman; Viggo F I Van Tendeloo
Journal:  Oncologist       Date:  2012-08-20

Review 4.  Fibrosis-dependent mechanisms of hepatocarcinogenesis.

Authors:  David Y Zhang; Scott L Friedman
Journal:  Hepatology       Date:  2012-06-29       Impact factor: 17.425

5.  The anti-angiogenic activity of IL-12 is increased in iNOS-/- mice and involves NK cells.

Authors:  Aleksandra Bielawska-Pohl; Séverine Blesson; Houssem Benlalam; Aurélie Trenado; Paule Opolon; Olivia Bawa; Valérie Rouffiac; Danuta Dus; Claudine Kieda; Salem Chouaib
Journal:  J Mol Med (Berl)       Date:  2010-04-11       Impact factor: 4.599

6.  Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging.

Authors:  Judith Eckl; Alexander Buchner; Petra U Prinz; Rainer Riesenberg; Sabine I Siegert; Robert Kammerer; Peter J Nelson; Elfriede Noessner
Journal:  J Mol Med (Berl)       Date:  2011-08-26       Impact factor: 4.599

7.  Hemacytotoxicity and natural killer lytic index: New parameters to evaluate natural killer cell immunity for clinical use in cancer.

Authors:  Hyung Gun Maeng; Su Jin Lee; Yun A Lee; Hye Jeong Lee; Young Joo Kim; Jong Kyun Lee; Jae Cheol Kim; Joungbum Choi
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

8.  Homing of radiolabelled recombinant interleukin-2 activated natural killer cells and their efficacy in adoptive immunotherapy against murine fibrosarcoma.

Authors:  Anuradha Rai; Ashim K Chakravarty
Journal:  J Biosci       Date:  2007-12       Impact factor: 1.826

9.  Shaping of NK cell responses by the tumor microenvironment.

Authors:  Ana Stojanovic; Margareta P Correia; Adelheid Cerwenka
Journal:  Cancer Microenviron       Date:  2012-12-16

Review 10.  Strategies to enhance rituximab anti-tumor activity in the treatment of CD20-positive B-cell neoplasms.

Authors:  Wasif Riaz; Francisco J Hernandez-Ilizaliturri; Myron S Czuczman
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.